What We Offer We tailor your plan using one or more of the following: GLP-1 medications (semaglutide, tirzepatide, etc.) Prescription oral weight loss medication Peptides for metabolism, lean mass, and appetite regulation Nutrition + lifestyle coaching Hormone evaluation if needed Pricing varies based on dose, vial size, and specific treatment plan
During the same timeframe during which Ozempic utilization increased by 75%, Trulicity utilization increased only 25%.3 Making a coverage change to a less utilized GLP-1 can rapidly decrease utilization for health plans that are facing unsustainable increases in GLP-1 usage, while preserving options for members who need GLP-1s to remain healthy
[1] "Human Growth Hormone Fragment 176-191 - Search Results - PubMed"
Mounjaro is licensed both as a treatment option for type 2 diabetes and weight management, making it a versatile choice for people looking for assistance when losing weight and for those struggling with both obesity and diabetes
Novo Nordisks blockbuster diabetes and weight loss drugs Ozempic and Wegovy may have a potential link with an eye condition that causes vision loss, according to a new study published Wednesday in JAMA Ophthalmology Novo Nordisks blockbuster diabetes and weight loss drugs Ozempic and Wegovy may have a potential link with an eye condition that causes vision loss, according to a new study published Wednesday in JAMA Ophthalmology